3 drug-delivery device ‘firsts’ win awards

Creating a new package in the highly regulated medical industry isn’t easy. When it happens, it should be rewarded. So we’re pleased to present the winners in the 2019 Medical Design Excellence Awards (MDEA) competition for the Drug-Delivery and Combination Products category.

Medtech’s brightest and most innovative developers recently attended the premier awards ceremony for the industry. Winners accepted their awards on Tues., June 11, in New York during the MD&M East event, which is co-located with EastPack. Both events are owned by Informa, the parent company of Packaging Digest and MD+DI publications.

The MDEAs accept entries from companies and individuals involved in the design, engineering, manufacturing, or distribution of finished medical devices. Jurors—made up of clinicians, engineers and designers—carefully review entries and select up to six finalists in each category. They then vote whether to award a bronze, silver and gold award in each category, as well as select an overall best-in-show winner.

Entries in the Drug-Delivery and Combination Products category can include packages such as prefilled syringes, misting devices, dry powder inhalers, patches, pouches or combination implants with biologic agents.

Of the five finalists in the Drug-Delivery and Combination Products category, the 2019 winners are:

Eluvia

Bronze: Eluvia Drug Eluting Vascular Stent from Boston Scientific Corp.

The Eluvia Drug-Eluting Vascular Stent System is the first and only drug-eluting technology designed to sustain drug release beyond a year to deliver drug therapy when restenosis (the recurrence of abnormal narrowing of an artery or valve after corrective surgery) is most likely to occur in the superficial femoral artery (the main artery of the leg).

 

clEARdropper

Silver: clEARdropper from AJB LLC

clEARdropper is the first over-the-counter ear drug-delivery device, solving the problems of accurate ear drug dosing, waste and self-administration with a simple, waste-eliminating, cost-reducing design that addresses the delivery challenges and unique anatomy of the ear.

Supply and Design Credits: Rubber Industries Inc.

Bydureon BCise

Gold: Bydureon BCise from AstraZeneca

Bydureon BCise is a fixed-dose autoinjector for convenient dose preparation (re-suspension) and self-injection by patients with Type 2 diabetes. It is the first cartridge-based autoinjector. Needle and cartridge form a fluid path only immediately before administration. The users were fundamental in determining the appropriate device activation mechanism, the form factors and device feedback.

Supply and Design Credits: SHL Medical AG

Filed Under:
By submitting this form, you accept the Mollom privacy policy.
500 characters remaining